Metformin and reduced risk of cancer in diabetic patients - Wikidata - awgldk - TriplyDB

Metformin and reduced risk of cancer in diabetic patients

Metformin and reduced risk of cancer in diabetic patients

http://www.wikidata.org/entity/Q29616275

about

Risk of cancer in diabetes: the effect of metformin Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications Repurposing metformin: an old drug with new tricks in its binding pockets Molecular mechanism of action of metformin: old or new insights?Understanding the Warburg effect: the metabolic requirements of cell proliferation Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Targeting Cancer Metabolism - Revisiting the Warburg Effects Regulation and function of AMPK in physiology and diseases Diabetes mellitus and metformin in hepatocellular carcinoma Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Fundamentals of cancer metabolism AMPK activators: mechanisms of action and physiological activities Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs Downregulation of Reactive Oxygen Species in Apoptosis Current understanding of metformin effect on the control of hyperglycemia in diabetes Energy disruptors: rising stars in anticancer therapy?Obesity and cancer, a case for insulin signaling Obesity and cancer: mechanistic insights from transdisciplinary studies Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents Targeting LKB1 in cancer - exposing and exploiting vulnerabilities Diabetes and cancer: two diseases with obesity as a common risk factor Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies Metabolism and breast cancer risk: frontiers in research and practice Components of cancer metabolism and therapeutic interventions AMPK as a potential anticancer target - friend or foe?Adipocytes: impact on tumor growth and potential sites for therapeutic intervention Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review Metformin: Current knowledge Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment AMP-activated protein kinase: a target for drugs both ancient and modern Something old, something new and something very old: drugs for treating type 2 diabetes AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function Autophagy and cancer Metformin and the risk of cancer: time-related biases in observational studies Chemoprevention of cancer: current evidence and future prospects AMPK: a target for drugs and natural products with effects on both diabetes and cancer Old drug, new trick: repurposing metformin for gynecologic cancers?

P2860

Q21284807-21FDE976-7444-464B-9685-39EA3FEA4E28 Q22242884-AD19037D-FA56-4FE9-958C-C1FB11C43D9F Q22250976-E0511754-7743-459D-A6C2-E47250021304 Q22252798-F03CE190-CC04-4C01-82B4-CDCF7D6E0D46 Q24604760-F88FDB83-563F-45DF-B091-5A32D44EF5BE Q24642412-61178E04-ECE3-4808-9153-3B31BFE06B81 Q24654974-88651ADC-B5FF-4480-9923-40ABE3F75FC6 Q24655078-BF4BFC07-513D-4811-A2BC-1B5A0A8E8279 Q24745996-F22207DF-A8C2-4C88-8E5D-37155CF292A5 Q26738876-98A3450A-FA8D-4105-A104-491B6F304E53 Q26740291-21425840-97C9-45FE-B130-1107E8E93B85 Q26741205-590D8144-0D64-4ADE-B32B-9144F4ADFD33 Q26741846-CE827854-0305-4C18-BEE0-1F46E439D5DE Q26744062-122A3BF1-ECB1-40F2-8684-D17E5098C63F Q26749158-A13566F2-0212-4DEB-9F6A-F0C74355D6E0 Q26750845-ACDAA8F1-2853-4E4E-AA85-6D1989EBC4E4 Q26751139-40B6CCBB-0994-4047-A52C-EC22C5A347D8 Q26770236-8311327B-45EA-4ECC-B178-7C1ABD592A69 Q26771300-274BC85A-C3C2-47D3-89A8-E5FF0FCFC683 Q26771452-A52CA8F9-D8B7-4D73-B515-CA3572B438E8 Q26786829-3C42CEC7-766A-4415-A6D5-AF93E4F649BC Q26800890-8CEC0320-5BA5-4D3C-B467-BFF7061E3183 Q26801412-DA5F3D6D-6783-499F-AC8C-0466BF846A6A Q26822753-0E7341C3-CE8F-4F3C-BACB-ECD8D75F0C5F Q26823118-0F074F0B-9C62-484F-B7EC-B1E51997E1EE Q26823745-B4CF341F-955D-4C69-9475-C474916C6C52 Q26823746-0F597E50-CFEF-4BA7-939E-DDE861569DC8 Q26829427-A475F260-7C56-4F0D-B82E-49EF57BA51E6 Q26830077-7D9F8BC0-B466-4AA0-9482-0ADE3B6CE5DF Q26850912-6D9FB877-A45B-4FE6-946B-A1DF4B2D4702 Q26853666-53DB8F36-510A-4217-9550-96D512E342F4 Q26860246-22E9FC52-347C-4571-A17F-E808FD6CBFC6 Q26864424-02563D32-3F8F-4BBB-B79E-6BCF7CB66442 Q26865663-F5994964-7E6A-47DB-A827-BFECF415FA59 Q26865723-028CC14B-86A8-4043-B13E-E16A1AB7ABF1 Q26865957-5F38E851-5581-4D68-89FE-E46647F58023 Q26999266-ECA3734F-826A-44AA-8950-A47EC72874F7 Q27000363-AEAEB353-3846-4E00-AC9D-01AB52E9F01E Q27002908-EE962395-847D-4DEC-8AB6-DDA5CAA3B4DE Q27010558-2CA0E3CC-7CCB-4A73-BC27-66632D676434

P2860

Metformin and reduced risk of cancer in diabetic patients

http://www.wikidata.org/entity/Q29616275

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Metformin and reduced risk of cancer in diabetic patients

@ast

Metformin and reduced risk of cancer in diabetic patients

@en

type

label

Metformin and reduced risk of cancer in diabetic patients

@ast

Metformin and reduced risk of cancer in diabetic patients

@en

prefLabel

Metformin and reduced risk of cancer in diabetic patients

@ast

Metformin and reduced risk of cancer in diabetic patients

@en

P1433

Q29616275-FAC2F7BA-1442-45A8-80DF-343DD23776F5

P1476

Q29616275-93835811-CFB4-4409-94AD-D9749E2AFB57

P2093

Q29616275-001E9F77-98B9-4CD7-93F2-A674B2FA56F4

Q29616275-4ADF104F-78D2-4DB4-BDDC-1856F93ABA98

Q29616275-66EAA1AB-30DF-4B93-AD26-47B66FC19A21

Q29616275-C65183DC-F7B2-496E-89CF-25E178F5E1FD

P2860

Q29616275-3A472C80-80ED-43DA-B489-25B0C33CC640

Q29616275-5345D4A4-70B8-4A3B-9FD5-6B1067207DDA

Q29616275-B42052D3-EBA4-4935-B4A9-99F1A9212B88

Q29616275-D4577B74-6E43-4714-9BA2-F30AAB5FF2B5

Q29616275-F1024B27-F405-4ACA-861B-D44193D18A88

P304

Q29616275-3F4C2DFC-55B2-4578-82C3-DCCFC0B929C2

P31

Q29616275-19521B8B-15B3-4850-BCCA-D9BB014F1D4F

P3181

Q29616275-BA0103AD-5763-4D58-A055-A90F2DF4E6AF

P356

Q29616275-BE8F7AC5-C843-46C5-AE53-550502858BAB

P407

Q29616275-DF3C8110-EBB8-47B1-AD80-7C65397E6625

P433

Q29616275-F634FBC2-0690-4A0F-BDF0-B7B35BF55A95

P478

Q29616275-73C3CC67-98E5-48CC-8F7F-04BBBE813C04

P50

Q29616275-27002F33-7ED8-405C-87D1-4318B7F421DB

P577

Q29616275-9291B16D-E2E3-4224-B6BB-0AA1E80F2170

P698

Q29616275-722F4C71-3F5F-4683-9DE6-0B793EAEE9CF

P921

Q29616275-4B952F41-A995-4613-87BB-4FEBBDCC2D8F

P932

Q29616275-B3AEC7A7-37FF-490B-833C-5C7E9AEEFF14

P3181

P356

BMJ.38415.708634.F7

P1433

P1476

Metformin and reduced risk of cancer in diabetic patients

@en

P2093

Alistair M Emslie-Smith

http://www.w3.org/2001/XMLSchema#string

Andrew D Morris

http://www.w3.org/2001/XMLSchema#string

Josie M M Evans

http://www.w3.org/2001/XMLSchema#string

Louise A Donnelly

http://www.w3.org/2001/XMLSchema#string

P2860

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003.

The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration.

Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study.

P304

1304-1305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

52359

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.38415.708634.F7

http://www.w3.org/2001/XMLSchema#string

P407

P433

7503

http://www.w3.org/2001/XMLSchema#string

P478

330

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15849206

http://www.w3.org/2001/XMLSchema#string

P921

P932

558205

http://www.w3.org/2001/XMLSchema#string